A股異動丨協鑫集成(002506.SZ)大漲7% 集成電路新政將對公司項目產生積極影響
格隆匯8月7日丨協鑫集成(002506.SZ)逆勢大漲6.9%,報4.03元,成交額放大至30.1億元,最新總市值204.8億元。受政策支持影響,公司此前已收穫2連漲停。協鑫集成昨日發佈股價異動公告稱,根據國務院7月27日頒佈的《新時期促進集成電路產業和軟件產業高質量發展的若干政策》,預計將對公司前期投資的鑫晶半導體項目及再生晶圓項目產生積極影響。另外,日前定增申請獲證監會審核通過。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.